Strict regular use of Ivermectin as a prophylaxis for covid19 leads to a 90% reduction in mortality rate

This is a preprint article on Research Gate. Data from a prospective observational study  including 223,128 subjects from a city-wide program in Southern Brazil concluding that regular use of ivermectin as prophylaxis for COVID-19 leads to a 90% reduction in COVID-19 mortality rate. This is a preprint article, notably early-stage research may not have been peer reviewed yet.

Leave a Comment

Your email address will not be published. Required fields are marked *